Phase 3 Ocular Hypertension Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
Qlaris Bio, Inc.60 enrolled1 locationNCT07354516
Recruiting
Phase 3
Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Ocular HypertensionPrimary Open Angle Glaucoma (POAG)
Huons Co., Ltd.206 enrolled1 locationNCT07335211
Recruiting
Phase 3
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
CataractGlaucomaOcular Hypertension
SpyGlass Pharma, Inc.400 enrolled1 locationNCT07218796
Recruiting
Phase 3
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
CataractGlaucomaOcular Hypertension
SpyGlass Pharma, Inc.400 enrolled1 locationNCT07218783
Recruiting
Phase 3
Clarifying the Optimal Application of SLT Therapy Trial
Glaucoma and Ocular Hypertension
University of Pittsburgh790 enrolled29 locationsNCT04967989
Recruiting
Phase 3
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd.338 enrolled25 locationsNCT06666855
Recruiting
Phase 3
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Ocular HypertensionGlaucoma, Open-Angle
Amneal Pharmaceuticals, LLC168 enrolled9 locationsNCT05401357